Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Luteolin
Cat. No.:
OB0225LY-0354
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Luteolin is a flavonoid compound found in a variety of plants and has a wide range of biological activities.
Synonym:
Luteolol; Flacitran; Digitoflavone; Luteoline; 491-70-3; 3',4',5,7-Tetrahydroxyflavone; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-chromenone; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one
CAS No.:
491-70-3
Compound CID:
5280445
Formula:
C15H10O6
Formula Weight:
286.24
Specification
Relative Density:
1.2981 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Luteolin can be used to study anti-inflammatory and antioxidant effects.
Library Information
Targets:
PDE family; Nrf2
Receptors:
Keap1-Nrf2; PDE1; PDE2; PDE3; PDE4; PDE5
Pathways:
Apoptosis; Metabolism; Immunology/Inflammation; Autophagy
Plate Number:
AOCL-5
Plate Location:
e9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 192.15 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
3 mg/mL
Solubility:
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5.7 mg/mL (19.91 mM)
